Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria

International Journal for Parasitology

Volumn 41, Issue 1, 2011, Pages 21-31

  Bucher, Kirsten ^a   Dietz, Klaus ^a   Lackner, Peter ^b   Pasche, Bastian ^c   Fendel, Rolf ^a   Mordmüller, Benjamin ^a   Ben Smith, Anne ^d   Hoffmann, Wolfgang H ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d Maame Akua ^*  (Germany)

Author keywords

Brain pathology; Cerebral malaria; Hypothermia; IFN ; Pro inflammatory chemokines; Schistosomiasis; Survival; Weight loss

Indexed keywords

CXCL9 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; LACTIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1;

BRAIN; IMMUNE RESPONSE; MALARIA; PARASITE; PATHOLOGY; SCHISTOSOMIASIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BRAIN MALARIA; CELL SURVIVAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; HEMATOCRIT; IMMUNOMODULATION; LACTATE BLOOD LEVEL; MIXED INFECTION; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PROTEIN BLOOD LEVEL; RETICULOCYTE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; BRAIN DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HYPOTHERMIA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PARASITEMIA; PLASMODIUM BERGHEI; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

ANIMALIA; MURINAE; MUS; PLASMODIUM BERGHEI; SCHISTOSOMA; SCHISTOSOMA MANSONI; VERMES;

EID: 78650175924     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.06.008     Document Type: Article

References (44)

1. Armah H.B., Wilson N.O., Sarfo B.Y., Powell M.D., Bond V.C., Anderson W., Adjei A.A., Gyasi R.K., Tettey Y., Wiredu E.K., Tongren J.E., Udhayakumar V., Stiles J.K. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 2007, 6:147-164.
2. Belnoue E., Potter S.M., Rosa D.S., Mauduit M., Gruner A.C., Kayibanda M., Mitchell A.J., Hunt N.H., Renia L. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008, 30:544-553.
3. Briand V., Watier L., Le Hesran J.Y., Garcia A., Cot M. Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children?. Am. J. Trop. Med. Hyg. 2005, 72:702-707.
4. Campanella G.S., Tager A.M., El Khoury J.K., Thomas S.Y., Abrazinski T.A., Manice L.A., Colvin R.A., Luster A.D. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 2008, 105:4814-4819.
5. Chabasse D., Bertrand G., Leroux J.P., Gauthey N., Hocquet P. Developmental bilharziasis caused by Schistosoma mansoni discovered 37 years after infestation. Bull. Soc. Pathol. Exot. Filiales. 1985, 78:643-647.
6. Chang W.L., Jones S.P., Lefer D.J., Welbourne T., Sun G., Yin L., Suzuki H., Huang J., Granger D.N., Van Der Heyde H.C. CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect. Immun. 2001, 69:7341-7348.
7. Christensen N.O., Furu P., Kurtzhals J., Odaibo A. Heterologous synergistic interactions in concurrent experimental infection in the mouse with Schistosoma mansoni, Echinostoma revolutum, Plasmodium yoelii, Babesia microti, and Trypanosoma brucei. Parasitol. Res. 1988, 74:544-551.
8. de Souza B., Helmby H. Concurrent gastro-intestinal nematode infection does not alter the development of experimental cerebral malaria. Microbes Infect. 2008, 10:916-921.
9. Dunne D.W., Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat. Rev. Immunol. 2005, 5:420-426.
10. Engwerda C.R., Mynott T.L., Sawhney S., de Souza J.B., Bickle Q.D., Kaye P.M. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 2002, 195:1371-1377.
11. Favre N., Da Laperousaz C., Ryffel B., Weiss N.A., Imhof B.A., Rudin W., Lucas R., Piguet P.F. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999, 1:961-968.
12. Fernandez R.D., Dubben B., Saeftel M., Endl E., Deininger S., Hoerauf A., Specht S. Filarial infection induces protection against P. berghei liver stages in mice. Microbes Infect. 2009, 11:172-180.
13. Graham A.L., Lamb T.J., Read A.F., Allen J.E. Malaria-filaria coinfection in mice makes malarial disease more severe unless filarial infection achieves patency. J. Infect. Dis. 2005, 191:410-421.
14. Hamm D.M., Agossou A., Gantin R.G., Kocherscheidt L., Banla M., Dietz K., Soboslay P.T. Coinfections with Schistosoma haematobium, Necator americanus, and Entamoeba histolytica/Entamoeba dispar in children: chemokine and cytokine responses and changes after antiparasite treatment. J. Infect. Dis. 2009, 199:1583-1591.
15. Hartgers F.C., Obeng B.B., Boakye D., Yazdanbakhsh M. Immune responses during helminth-malaria co-infection: a pilot study in Ghanaian school children. Parasitology 2008, 135:855-860.
16. Hartgers F.C., Yazdanbakhsh M. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol. 2006, 28:497-506.
17. Helmby H., Kullberg M., Troye-Blomberg M. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 1998, 66:5167-5174.
18. Hoffmann K.F., Cheever A.W., Wynn T.A. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 2000, 164:6406-6416.
19. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
20. La Flamme A.C., Ruddenklau K., Backstrom B.T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 2003, 71:4996-5004.
21. Lackner P., Beer R., Heussler V., Goebel G., Rudzki D., Helbok R., Tannich E., Schmutzhard E. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol. Appl. Neurobiol. 2006, 32:177-188.
22. Le Hesran J.Y., Akiana J., Ndiaye e.H., Dia M., Senghor P., Konate L. Severe malaria attack is associated with high prevalence of Ascaris lumbricoides infection among children in rural Senegal. Trans. R. Soc. Trop. Med. Hyg. 2004, 98:397-399.
23. Löhning M., Grogan J.L., Coyle A.J., Yazdanbakhsh M., Meisel C., Gutierrez-Ramos J.C., Radbruch A., Kamradt T. T1/ST2 expression is enhanced on CD4+ T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. J. Immunol. 1999, 162:3882-3889.
24. Lou J., Lucas R., Grau G.E. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 2001, 14:810-820.
25. Lwin M., Last C., Targett G.A., Doenhoff M.J. Infection of mice concurrently with Schistosoma mansoni and rodent malarias: contrasting effects of patent S. mansoni infections on Plasmodium chabaudi, P. yoelii and P. berghei. Ann. Trop. Med. Parasitol. 1982, 76:265-273.
26. Lyke K.E., Dicko A., Dabo A., Sangare L., Kone A., Coulibaly D., Guindo A., Traore K., Daou M., Diarra I., Sztein M.B., Plowe C.V., Doumbo O.K. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am. J. Trop. Med. Hyg. 2005, 73:1124-1130.
27. Maizels R.M., Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol. 2003, 3:733-744.
28. Maizels R.M., Balic A., Gomez-Escobar N., Nair M., Taylor M.D., Allen J.E. Helminth parasites - masters of regulation. Immunol. Rev. 2004, 201:89-116.
29. Nacher M., Gay F., Singhasivanon P., Krudsood S., Treeprasertsuk S., Mazier D., Vouldoukis I., Looareesuwan S. Ascaris lumbricoides infection is associated with protection from cerebral malaria. Parasite Immunol. 2000, 22:107-113.
30. Nacher M., Singhasivanon P., Yimsamran S., Manibunyong W., Thanyavanich N., Wuthisen R., Looareesuwan S. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J. Parasitol. 2002, 88:55-58.
31. Otten-Kuipers M.A., Franssen F.F., Nieuwenhuijs H., Overdulve J.P., Roelofsen B., Op den Kamp J.A. Effect of tryptophan-N-formylated gramicidin on growth of Plasmodium berghei in mice. Antimicrob. Agents Chemother. 1997, 41:1778-1782.
32. Piguet P.F., Kan C.D., Vesin C. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab. Invest. 2002, 82:1155-1166.
33. Raso G., Luginbuhl A., Adjoua C.A., Tian-Bi N.T., Silue K.D., Matthys B., Vounatsou P., Wang Y., Dumas M.E., Holmes E., Singer B.H., Tanner M., N'goran E.K., Utzinger J. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote d'Ivoire. Int. J. Epidemiol. 2004, 33:1092-1102.
34. Sangweme D., Shiff C., Kumar N. Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp. Parasitol. 2009, 122:254-259.
35. Singh K.P., Gerard H.C., Hudson A.P., Reddy T.R., Boros D.L. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 2005, 114:410-417.
36. Smithers S.R., Terry R.J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 1965, 55:695-700.
37. Snow R.W., Trape J.F., Marsh K. The past, present and future of childhood malaria mortality in Africa. Trends Parasitol. 2001, 17:593-597.
38. Su Z., Segura M., Morgan K., Loredo-Osti J.C., Stevenson M.M. Impairment of protective immunity to blood-stage malaria by concurrent nematode infection. Infect. Immun. 2005, 73:3531-3539.
39. Van Der Heyde H.C., Pepper B., Batchelder J., Cigel F., Weidanz W.P. The time course of selected malarial infections in cytokine-deficient mice. Exp. Parasitol. 1997, 85:206-213.
40. Waknine-Grinberg J., Gold D., Ohayon A., Flescher E., Heyfets A., Doenhoff M.J., Schramm G., Haas H., Golenser J. Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malar. J. 2010, 9:5-16.
41. Weiser S., Miu J., Ball H.J., Hunt N.H. Interferon-gamma synergises with tumour necrosis factor and lymphotoxin-alpha to enhance the mRNA and protein expression of adhesion molecules in mouse brain endothelial cells. Cytokine 2007, 37:84-91.
42. Yan Y., Inuo G., Akao N., Tsukidate S., Fujita K. Down-regulation of murine susceptibility to cerebral malaria by inoculation with third-stage larvae of the filarial nematode Brugia pahangi. Parasitology 1997, 114:333-338.
43. Yoneto T., Yoshimoto T., Wang C.R., Takahama Y., Tsuji M., Waki S., Nariuchi H. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect. Immun. 1999, 67:2349-2356.
44. Yoshida A., Maruyama H., Kumagai T., Amano T., Kobayashi F., Zhang M., Himeno K., Ohta N. Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice. Int. Immunol. 2000, 12:1117-1125.